Care

Atropos Health CEO, Brigham Hyde, discusses the integration of Atropos' agentic AI agent into Microsoft Teams, helping clinical teams analyze patient information and clinical documentation during team meetings to support decision making.

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.

The department is proposing to reorganize the Veterans Health Administration health agency over the next 18-24 months. Meanwhile, new proposed House bills seek VA reforms.

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.

The company also raised $5 million in venture debt funding.

Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce burden and extend cancer care into the home.

According to Kevin Ritter of Altera Digital Health, health systems must go beyond simple information exchange to ensure their data is discrete, normalized and able to flow between multiple applications across the enterprise.

Executives pointed to faster-than-expected AI adoption in healthcare, shifting regulatory signals and growing demand for AI tools that deliver measurable outcomes.